ES2144034T3 - Composiciones farmaceuticas estables que contienen alfa-interferon hibrido. - Google Patents

Composiciones farmaceuticas estables que contienen alfa-interferon hibrido.

Info

Publication number
ES2144034T3
ES2144034T3 ES94305930T ES94305930T ES2144034T3 ES 2144034 T3 ES2144034 T3 ES 2144034T3 ES 94305930 T ES94305930 T ES 94305930T ES 94305930 T ES94305930 T ES 94305930T ES 2144034 T3 ES2144034 T3 ES 2144034T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
stable pharmaceutical
containing alpha
interferon hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94305930T
Other languages
English (en)
Inventor
Nicholas Lowther
John Douglas Allen
Colin Howes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939316849A external-priority patent/GB9316849D0/en
Priority claimed from GB9405879A external-priority patent/GB9405879D0/en
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2144034T3 publication Critical patent/ES2144034T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UNA SOLUCION ACUOSA ESTABLE DE INTERFERON HIBRIDO QUE CONTIENE COMO ESTABILIZADOR UN REACTIVO COMPENSADOR A UN PH ENTRE 3''0 Y 5''0
ES94305930T 1993-08-13 1994-08-10 Composiciones farmaceuticas estables que contienen alfa-interferon hibrido. Expired - Lifetime ES2144034T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939316849A GB9316849D0 (en) 1993-08-13 1993-08-13 Pharmaceutical compositions
GB9405879A GB9405879D0 (en) 1994-03-24 1994-03-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2144034T3 true ES2144034T3 (es) 2000-06-01

Family

ID=26303371

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94305930T Expired - Lifetime ES2144034T3 (es) 1993-08-13 1994-08-10 Composiciones farmaceuticas estables que contienen alfa-interferon hibrido.

Country Status (19)

Country Link
US (1) US5609868A (es)
EP (1) EP0641567B1 (es)
JP (1) JP3745395B2 (es)
KR (1) KR100351495B1 (es)
AT (1) ATE190498T1 (es)
AU (1) AU679233B2 (es)
CA (1) CA2129921C (es)
CY (1) CY2230B1 (es)
DE (1) DE69423402T2 (es)
DK (1) DK0641567T3 (es)
ES (1) ES2144034T3 (es)
FI (1) FI111222B (es)
GR (1) GR3033239T3 (es)
HU (1) HU224613B1 (es)
IL (1) IL110566A (es)
NO (1) NO315843B1 (es)
NZ (1) NZ264218A (es)
PT (1) PT641567E (es)
TW (1) TW249202B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
EA002754B1 (ru) * 1996-12-24 2002-08-29 Байоджен, Инк. Устойчивые жидкие составы интерферона
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
KR19990075253A (ko) * 1998-03-18 1999-10-15 성재갑 약학적으로 안정한 인터페론 제
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
ES2167189B1 (es) * 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
AU3070702A (en) 2000-11-07 2002-05-21 Chiron Corp Stabilized inteferon compositions
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
AR044302A1 (es) * 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
WO2007000769A2 (en) * 2005-06-29 2007-01-04 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science RECOMBINANT INTERFERON α2 (IFNα2) MUTANTS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59196823A (ja) * 1983-04-20 1984-11-08 Sunstar Inc 皮膚および粘膜の真菌症治療用外用剤
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
PT82249B (en) * 1985-03-25 1988-01-07 Schering Corp Process for preparing stable gamma-interferon formulations
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US4847079A (en) * 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer

Also Published As

Publication number Publication date
CY2230B1 (en) 2003-04-18
NZ264218A (en) 1995-07-26
DE69423402T2 (de) 2000-08-03
DE69423402D1 (de) 2000-04-20
AU679233B2 (en) 1997-06-26
TW249202B (es) 1995-06-11
FI943705A0 (fi) 1994-08-10
GR3033239T3 (en) 2000-09-29
DK0641567T3 (da) 2000-08-14
IL110566A (en) 1999-12-22
EP0641567A1 (en) 1995-03-08
HUT68692A (en) 1995-07-28
FI943705A (fi) 1995-02-14
KR950005325A (ko) 1995-03-20
NO942983L (no) 1995-02-14
JP3745395B2 (ja) 2006-02-15
KR100351495B1 (ko) 2003-02-19
FI111222B (fi) 2003-06-30
CA2129921A1 (en) 1995-02-14
PT641567E (pt) 2000-08-31
IL110566A0 (en) 1995-01-24
US5609868A (en) 1997-03-11
NO315843B1 (no) 2003-11-03
CA2129921C (en) 2006-12-05
EP0641567B1 (en) 2000-03-15
HU224613B1 (hu) 2005-11-28
HU9402356D0 (en) 1994-10-28
AU6893994A (en) 1995-02-23
NO942983D0 (no) 1994-08-12
JPH07145070A (ja) 1995-06-06
ATE190498T1 (de) 2000-04-15

Similar Documents

Publication Publication Date Title
IT1283588B1 (it) Miscela sinergica di agenti stabilizzanti
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DK1273299T3 (da) Minoxidilinindeholdende praparater
MX9403915A (es) Derivados de n-alquiltio de pliamina como agentes radioprotectores.
ES2144034T3 (es) Composiciones farmaceuticas estables que contienen alfa-interferon hibrido.
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
DE69921151D1 (de) Fluorszierende marker
BR9805265A (pt) Sìlicas precipitadas que contêm uma substância ativa.
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69328900T2 (de) Verfahren zur Reinigung von Teppichen
PT745081E (pt) Derivados de dissulfureto de inda-2-mercaptoacetilamida uteis como inibidores da encefalinase
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
EA199900888A1 (ru) Противоревматические средства
ATE182897T1 (de) N-amidino- dermorphin-derivat
DE3577970D1 (de) Desinfektionszusammensetzungen.
ES2195309T3 (es) Derivados de tetrahidrofurano.
UA6882C2 (uk) Стерилізуючий засіб
DE69615814T2 (de) Uch-15-verbindungen
ITMI950971A1 (it) Derivati aminotiazolici di cefalosporine aventi attivita' antibatterica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 641567

Country of ref document: ES